| JYSB2500112 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products | Supplementary Application | 2025-05-01 | | Novo Nordisk A/S | | | view |
| CXSS2500030 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2025-02-20 | | Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd | | | view |
| CXSS2500025 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2025-02-09 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
| CXSS2500026 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2025-02-09 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
| CXSL2400772 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-11-13 | | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
| CXSS2400110 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2024-10-12 | | Zhuhai Federal Biomedical Co Ltd | | | view |
| CXSS2400109 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2024-10-12 | | Zhuhai Federal Biomedical Co Ltd | | | view |
| CXSL2400436 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-07-09 | | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
| CXSL2400293 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2024-05-09 | | Shandong New Time Pharmaceutical Co Ltd | | | view |
| JYSB2400035 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products(3.1) | Supplementary Application | 2024-02-27 | | Novo Nordisk A/S | | | view |
| CXSL2400105 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-02-07 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CXSL2400082 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2024-02-01 | | Dongguan HEC Biopharmaceutical R&D Co Ltd;Sunshine Lake Pharma Co Ltd | | | view |
| JYSB2400021 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products | Supplementary Application | 2024-02-01 | | Novo Nordisk A/S | | | view |
| CXSL2300515 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2023-07-26 | | Jilin Huisheng Biopharmaceutical Co Ltd | | | view |
| CXSL2300433 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2023-06-27 | | Fosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd | | | view |
| CXSL2300092 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products(3.3) | New Drug Application | 2023-02-08 | | The United Bio-Technology(Hengqin) Co Ltd | | | view |
| CYSB2300007 | 德谷胰岛素利拉鲁肽注射液 | insulin degludec;liraglutide | Injection | Biological Products | Supplementary Application | 2023-01-11 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| JYSB2200188 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2022-09-29 | | Novo Nordisk A/S | | | view |
| JYSB2200187 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2022-09-29 | | Novo Nordisk A/S | | | view |
| CYSB2200227 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products | Supplementary Application | 2022-09-15 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
